DRF 1644
Latest Information Update: 08 Feb 2008
At a glance
- Originator Dr Reddys Research Foundation
- Class
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Feb 2008 Discontinued - Phase-I for Cancer in India (unspecified route)
- 16 Apr 2007 No development reported - Preclinical for Cancer in India (unspecified route)
- 31 Mar 2004 Phase-I clinical trials in Cancer in India (unspecified route)